This content is machine translated Longevity Medicine 2025 From anti-ageing to precision prevention Longevity Medicine in 2025 is less a marketing term than a clinical work program: moving away from fuzzy “anti-aging” promises towards measurable risk, biomarker and intervention logic. Drivers are a...…
View Post 12 min This content is machine translated Diabetic ketoacidosis Recommendations for action in practice Diabetic ketoacidosis (DKA) is an acutely life-threatening complication of diabetes mellitus that occurs predominantly in type 1 diabetes, but is also increasingly occurring in people with type 2 diabetes. A...… CME-Test
View Post 13 min This content is machine translated Acute myeloid leukemia Treatment decisions between MRD monitoring, transplantation and CAR-T cells As part of the SOHC 2025 (Swiss Oncology & Hematology Congress), Christoph Röllig from Dresden University Hospital gave a presentation on current developments in the diagnosis and treatment of minimal...…
View Post 9 min This content is machine translated Myelofibrosis New treatment options for myelofibrosis patients with a high risk of anemia? Myelofibrosis is considered one of the most complex myeloproliferative neoplasms – with high symptom burden, progressive cytopenia and limited treatment options – with anemia in particular presenting a clinical challenge...…
View Post 12 min This content is machine translated Multiple myeloma DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14 The DREAMM-8 data presented at this year’s ASCO provided robust evidence of the efficacy and tolerability of the BPd combination (belantamab mafodotin, pomalidomide and dexamethasone) for the treatment of recurrent...…
View Post 5 min This content is machine translated Hemophilia A and B Personalized approach and innovative treatment options Severe haemophilia carries a high risk of life-threatening complications if left untreated. In addition to the classic therapeutic principle of substituting the missing coagulation factor, new treatment options have been...…
View Post 6 min This content is machine translated EHA 2025 Progress in multiple myeloma The annual meeting of the European Hematology Association (EHA) has been one of the most important focal points for international haematology for many years. With more than 15,000 participants on...…
View Post 7 min This content is machine translated Management of patients after alloHCST ERS/EBMT guideline recommendations on pulmonary cGvHD After an allogeneic stem cell transplant (alloHCST), life-threatening chronic graft-versus-host disease (cGvHD) occurs again and again. This is when the donor’s immune cells attack the recipient’s body. Lung involvement in...…
View Post 4 min This content is machine translated Case series Bleeding prophylaxis for von Willebrand disease Von Willebrand’s disease is predominantly inherited in an autosomal dominant manner and is the most common hereditary cause of a bleeding tendency. It is caused by a quantitative and/or qualitative...…
View Post 5 min This content is machine translated Acute leukemia: Disease management Priorities from the perspective of patients and family caregivers Studies launched by the patient organization ALAN (The Acute Leukemia Advocates Network) map patient preferences in acute leukemia on the one hand and record the situation of relatives involved in...…
View Post 6 min This content is machine translated Update on diagnostics, risk stratification and therapy Acute myeloid leukemia 2025 Acute myeloid leukemia (AML) remains one of the greatest challenges in hematology. Despite established chemotherapy protocols, the prognosis for many patients remains unfavorable. In recent years, however, new molecular classifications,...…
